img

Global Aujeszky Disease Vaccines Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Aujeszky Disease Vaccines Market Insights, Forecast to 2034

The global Aujeszky Disease Vaccines market is projected to grow from US$ million in 2023 to US$ million by 2033, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Aujeszky Disease Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for Aujeszky Disease Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for Aujeszky Disease Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key manufacturers of Aujeszky Disease Vaccines include IDEXX, Ceva, MSD Animal Health, Kyoritsuseiyaku Corporation, CAVAC, HIPRA and Zendal group(CZ Vaccines), etc. In 2022, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Aujeszky Disease Vaccines production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2033.
In terms of consumption side, this report focuses on the sales of Aujeszky Disease Vaccines by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2033.

Report Includes


This report presents an overview of global market for Aujeszky Disease Vaccines, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of Aujeszky Disease Vaccines, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Aujeszky Disease Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Aujeszky Disease Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Aujeszky Disease Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2033. Evaluation and forecast the market size for Aujeszky Disease Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including IDEXX, Ceva, MSD Animal Health, Kyoritsuseiyaku Corporation, CAVAC, HIPRA and Zendal group(CZ Vaccines), etc.



By Company


IDEXX
Ceva
MSD Animal Health
Kyoritsuseiyaku Corporation
CAVAC
HIPRA
Zendal group(CZ Vaccines)
Segment by Type
Freeze-dried Tablet
Injection

Segment by Application


Sow
Piggy
Boar

Production by Region


North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Aujeszky Disease Vaccines production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3Sales (consumption), revenue of Aujeszky Disease Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4Detailed analysis of Aujeszky Disease Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9China by type and by application sales and revenue for each segment.
Chapter 10Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aujeszky Disease Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 13Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Aujeszky Disease Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Aujeszky Disease Vaccines Market Size by Type, 2018 VS 2022 VS 2033
1.2.2 Freeze-dried Tablet
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Aujeszky Disease Vaccines Market Size by Application, 2018 VS 2022 VS 2033
1.3.2 Sow
1.3.3 Piggy
1.3.4 Boar
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Aujeszky Disease Vaccines Production
2.1 Global Aujeszky Disease Vaccines Production Capacity (2018-2033)
2.2 Global Aujeszky Disease Vaccines Production by Region: 2018 VS 2022 VS 2033
2.3 Global Aujeszky Disease Vaccines Production by Region
2.3.1 Global Aujeszky Disease Vaccines Historic Production by Region (2018-2023)
2.3.2 Global Aujeszky Disease Vaccines Forecasted Production by Region (2024-2033)
2.3.3 Global Aujeszky Disease Vaccines Production Market Share by Region (2018-2033)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Aujeszky Disease Vaccines Revenue Estimates and Forecasts 2018-2033
3.2 Global Aujeszky Disease Vaccines Revenue by Region
3.2.1 Global Aujeszky Disease Vaccines Revenue by Region: 2018 VS 2022 VS 2033
3.2.2 Global Aujeszky Disease Vaccines Revenue by Region (2018-2023)
3.2.3 Global Aujeszky Disease Vaccines Revenue by Region (2024-2033)
3.2.4 Global Aujeszky Disease Vaccines Revenue Market Share by Region (2018-2033)
3.3 Global Aujeszky Disease Vaccines Sales Estimates and Forecasts 2018-2033
3.4 Global Aujeszky Disease Vaccines Sales by Region
3.4.1 Global Aujeszky Disease Vaccines Sales by Region: 2018 VS 2022 VS 2033
3.4.2 Global Aujeszky Disease Vaccines Sales by Region (2018-2023)
3.4.3 Global Aujeszky Disease Vaccines Sales by Region (2024-2033)
3.4.4 Global Aujeszky Disease Vaccines Sales Market Share by Region (2018-2033)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Aujeszky Disease Vaccines Sales by Manufacturers
4.1.1 Global Aujeszky Disease Vaccines Sales by Manufacturers (2018-2023)
4.1.2 Global Aujeszky Disease Vaccines Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aujeszky Disease Vaccines in 2022
4.2 Global Aujeszky Disease Vaccines Revenue by Manufacturers
4.2.1 Global Aujeszky Disease Vaccines Revenue by Manufacturers (2018-2023)
4.2.2 Global Aujeszky Disease Vaccines Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Aujeszky Disease Vaccines Revenue in 2022
4.3 Global Aujeszky Disease Vaccines Sales Price by Manufacturers
4.4 Global Key Players of Aujeszky Disease Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Aujeszky Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Aujeszky Disease Vaccines, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Aujeszky Disease Vaccines, Product Offered and Application
4.8 Global Key Manufacturers of Aujeszky Disease Vaccines, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Aujeszky Disease Vaccines Sales by Type
5.1.1 Global Aujeszky Disease Vaccines Historical Sales by Type (2018-2023)
5.1.2 Global Aujeszky Disease Vaccines Forecasted Sales by Type (2024-2033)
5.1.3 Global Aujeszky Disease Vaccines Sales Market Share by Type (2018-2033)
5.2 Global Aujeszky Disease Vaccines Revenue by Type
5.2.1 Global Aujeszky Disease Vaccines Historical Revenue by Type (2018-2023)
5.2.2 Global Aujeszky Disease Vaccines Forecasted Revenue by Type (2024-2033)
5.2.3 Global Aujeszky Disease Vaccines Revenue Market Share by Type (2018-2033)
5.3 Global Aujeszky Disease Vaccines Price by Type
5.3.1 Global Aujeszky Disease Vaccines Price by Type (2018-2023)
5.3.2 Global Aujeszky Disease Vaccines Price Forecast by Type (2024-2033)
6 Market Size by Application
6.1 Global Aujeszky Disease Vaccines Sales by Application
6.1.1 Global Aujeszky Disease Vaccines Historical Sales by Application (2018-2023)
6.1.2 Global Aujeszky Disease Vaccines Forecasted Sales by Application (2024-2033)
6.1.3 Global Aujeszky Disease Vaccines Sales Market Share by Application (2018-2033)
6.2 Global Aujeszky Disease Vaccines Revenue by Application
6.2.1 Global Aujeszky Disease Vaccines Historical Revenue by Application (2018-2023)
6.2.2 Global Aujeszky Disease Vaccines Forecasted Revenue by Application (2024-2033)
6.2.3 Global Aujeszky Disease Vaccines Revenue Market Share by Application (2018-2033)
6.3 Global Aujeszky Disease Vaccines Price by Application
6.3.1 Global Aujeszky Disease Vaccines Price by Application (2018-2023)
6.3.2 Global Aujeszky Disease Vaccines Price Forecast by Application (2024-2033)
7 US & Canada
7.1 US & Canada Aujeszky Disease Vaccines Market Size by Type
7.1.1 US & Canada Aujeszky Disease Vaccines Sales by Type (2018-2033)
7.1.2 US & Canada Aujeszky Disease Vaccines Revenue by Type (2018-2033)
7.2 US & Canada Aujeszky Disease Vaccines Market Size by Application
7.2.1 US & Canada Aujeszky Disease Vaccines Sales by Application (2018-2033)
7.2.2 US & Canada Aujeszky Disease Vaccines Revenue by Application (2018-2033)
7.3 US & Canada Aujeszky Disease Vaccines Sales by Country
7.3.1 US & Canada Aujeszky Disease Vaccines Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 US & Canada Aujeszky Disease Vaccines Sales by Country (2018-2033)
7.3.3 US & Canada Aujeszky Disease Vaccines Revenue by Country (2018-2033)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Aujeszky Disease Vaccines Market Size by Type
8.1.1 Europe Aujeszky Disease Vaccines Sales by Type (2018-2033)
8.1.2 Europe Aujeszky Disease Vaccines Revenue by Type (2018-2033)
8.2 Europe Aujeszky Disease Vaccines Market Size by Application
8.2.1 Europe Aujeszky Disease Vaccines Sales by Application (2018-2033)
8.2.2 Europe Aujeszky Disease Vaccines Revenue by Application (2018-2033)
8.3 Europe Aujeszky Disease Vaccines Sales by Country
8.3.1 Europe Aujeszky Disease Vaccines Revenue by Country: 2018 VS 2022 VS 2033
8.3.2 Europe Aujeszky Disease Vaccines Sales by Country (2018-2033)
8.3.3 Europe Aujeszky Disease Vaccines Revenue by Country (2018-2033)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Aujeszky Disease Vaccines Market Size by Type
9.1.1 China Aujeszky Disease Vaccines Sales by Type (2018-2033)
9.1.2 China Aujeszky Disease Vaccines Revenue by Type (2018-2033)
9.2 China Aujeszky Disease Vaccines Market Size by Application
9.2.1 China Aujeszky Disease Vaccines Sales by Application (2018-2033)
9.2.2 China Aujeszky Disease Vaccines Revenue by Application (2018-2033)
10 Asia (excluding China)
10.1 Asia Aujeszky Disease Vaccines Market Size by Type
10.1.1 Asia Aujeszky Disease Vaccines Sales by Type (2018-2033)
10.1.2 Asia Aujeszky Disease Vaccines Revenue by Type (2018-2033)
10.2 Asia Aujeszky Disease Vaccines Market Size by Application
10.2.1 Asia Aujeszky Disease Vaccines Sales by Application (2018-2033)
10.2.2 Asia Aujeszky Disease Vaccines Revenue by Application (2018-2033)
10.3 Asia Aujeszky Disease Vaccines Sales by Region
10.3.1 Asia Aujeszky Disease Vaccines Revenue by Region: 2018 VS 2022 VS 2033
10.3.2 Asia Aujeszky Disease Vaccines Revenue by Region (2018-2033)
10.3.3 Asia Aujeszky Disease Vaccines Sales by Region (2018-2033)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Aujeszky Disease Vaccines Market Size by Type
11.1.1 Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Type (2018-2033)
11.1.2 Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Type (2018-2033)
11.2 Middle East, Africa and Latin America Aujeszky Disease Vaccines Market Size by Application
11.2.1 Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Application (2018-2033)
11.2.2 Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Application (2018-2033)
11.3 Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Country
11.3.1 Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Country: 2018 VS 2022 VS 2033
11.3.2 Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Country (2018-2033)
11.3.3 Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Country (2018-2033)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 IDEXX
12.1.1 IDEXX Company Information
12.1.2 IDEXX Overview
12.1.3 IDEXX Aujeszky Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 IDEXX Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 IDEXX Recent Developments
12.2 Ceva
12.2.1 Ceva Company Information
12.2.2 Ceva Overview
12.2.3 Ceva Aujeszky Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Ceva Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Ceva Recent Developments
12.3 MSD Animal Health
12.3.1 MSD Animal Health Company Information
12.3.2 MSD Animal Health Overview
12.3.3 MSD Animal Health Aujeszky Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 MSD Animal Health Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 MSD Animal Health Recent Developments
12.4 Kyoritsuseiyaku Corporation
12.4.1 Kyoritsuseiyaku Corporation Company Information
12.4.2 Kyoritsuseiyaku Corporation Overview
12.4.3 Kyoritsuseiyaku Corporation Aujeszky Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Kyoritsuseiyaku Corporation Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Kyoritsuseiyaku Corporation Recent Developments
12.5 CAVAC
12.5.1 CAVAC Company Information
12.5.2 CAVAC Overview
12.5.3 CAVAC Aujeszky Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 CAVAC Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 CAVAC Recent Developments
12.6 HIPRA
12.6.1 HIPRA Company Information
12.6.2 HIPRA Overview
12.6.3 HIPRA Aujeszky Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 HIPRA Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 HIPRA Recent Developments
12.7 Zendal group(CZ Vaccines)
12.7.1 Zendal group(CZ Vaccines) Company Information
12.7.2 Zendal group(CZ Vaccines) Overview
12.7.3 Zendal group(CZ Vaccines) Aujeszky Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Zendal group(CZ Vaccines) Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zendal group(CZ Vaccines) Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Aujeszky Disease Vaccines Industry Chain Analysis
13.2 Aujeszky Disease Vaccines Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Aujeszky Disease Vaccines Production Mode & Process
13.4 Aujeszky Disease Vaccines Sales and Marketing
13.4.1 Aujeszky Disease Vaccines Sales Channels
13.4.2 Aujeszky Disease Vaccines Distributors
13.5 Aujeszky Disease Vaccines Customers
14 Aujeszky Disease Vaccines Market Dynamics
14.1 Aujeszky Disease Vaccines Industry Trends
14.2 Aujeszky Disease Vaccines Market Drivers
14.3 Aujeszky Disease Vaccines Market Challenges
14.4 Aujeszky Disease Vaccines Market Restraints
15 Key Finding in The Global Aujeszky Disease Vaccines Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Aujeszky Disease Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of Freeze-dried Tablet
Table 3. Major Manufacturers of Injection
Table 4. Global Aujeszky Disease Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 5. Global Aujeszky Disease Vaccines Production by Region: 2018 VS 2022 VS 2033 (K Units)
Table 6. Global Aujeszky Disease Vaccines Production by Region (2018-2023) & (K Units)
Table 7. Global Aujeszky Disease Vaccines Production by Region (2024-2033) & (K Units)
Table 8. Global Aujeszky Disease Vaccines Production Market Share by Region (2018-2023)
Table 9. Global Aujeszky Disease Vaccines Production Market Share by Region (2024-2033)
Table 10. Global Aujeszky Disease Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 11. Global Aujeszky Disease Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global Aujeszky Disease Vaccines Revenue by Region (2024-2033) & (US$ Million)
Table 13. Global Aujeszky Disease Vaccines Revenue Market Share by Region (2018-2023)
Table 14. Global Aujeszky Disease Vaccines Revenue Market Share by Region (2024-2033)
Table 15. Global Aujeszky Disease Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 16. Global Aujeszky Disease Vaccines Sales by Region (2018-2023) & (K Units)
Table 17. Global Aujeszky Disease Vaccines Sales by Region (2024-2033) & (K Units)
Table 18. Global Aujeszky Disease Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Aujeszky Disease Vaccines Sales Market Share by Region (2024-2033)
Table 20. Global Aujeszky Disease Vaccines Sales by Manufacturers (2018-2023) & (K Units)
Table 21. Global Aujeszky Disease Vaccines Sales Share by Manufacturers (2018-2023)
Table 22. Global Aujeszky Disease Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global Aujeszky Disease Vaccines Revenue Share by Manufacturers (2018-2023)
Table 24. Aujeszky Disease Vaccines Price by Manufacturers 2018-2023 (USD/Unit)
Table 25. Global Key Players of Aujeszky Disease Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 26. Global Aujeszky Disease Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Aujeszky Disease Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aujeszky Disease Vaccines as of 2022)
Table 28. Global Key Manufacturers of Aujeszky Disease Vaccines, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Aujeszky Disease Vaccines, Product Offered and Application
Table 30. Global Key Manufacturers of Aujeszky Disease Vaccines, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Aujeszky Disease Vaccines Sales by Type (2018-2023) & (K Units)
Table 33. Global Aujeszky Disease Vaccines Sales by Type (2024-2033) & (K Units)
Table 34. Global Aujeszky Disease Vaccines Sales Share by Type (2018-2023)
Table 35. Global Aujeszky Disease Vaccines Sales Share by Type (2024-2033)
Table 36. Global Aujeszky Disease Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global Aujeszky Disease Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 38. Global Aujeszky Disease Vaccines Revenue Share by Type (2018-2023)
Table 39. Global Aujeszky Disease Vaccines Revenue Share by Type (2024-2033)
Table 40. Aujeszky Disease Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 41. Global Aujeszky Disease Vaccines Price Forecast by Type (2024-2033) & (USD/Unit)
Table 42. Global Aujeszky Disease Vaccines Sales by Application (2018-2023) & (K Units)
Table 43. Global Aujeszky Disease Vaccines Sales by Application (2024-2033) & (K Units)
Table 44. Global Aujeszky Disease Vaccines Sales Share by Application (2018-2023)
Table 45. Global Aujeszky Disease Vaccines Sales Share by Application (2024-2033)
Table 46. Global Aujeszky Disease Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Aujeszky Disease Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 48. Global Aujeszky Disease Vaccines Revenue Share by Application (2018-2023)
Table 49. Global Aujeszky Disease Vaccines Revenue Share by Application (2024-2033)
Table 50. Aujeszky Disease Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 51. Global Aujeszky Disease Vaccines Price Forecast by Application (2024-2033) & (USD/Unit)
Table 52. US & Canada Aujeszky Disease Vaccines Sales by Type (2018-2023) & (K Units)
Table 53. US & Canada Aujeszky Disease Vaccines Sales by Type (2024-2033) & (K Units)
Table 54. US & Canada Aujeszky Disease Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada Aujeszky Disease Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 56. US & Canada Aujeszky Disease Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. US & Canada Aujeszky Disease Vaccines Sales by Application (2024-2033) & (K Units)
Table 58. US & Canada Aujeszky Disease Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada Aujeszky Disease Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 60. US & Canada Aujeszky Disease Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 61. US & Canada Aujeszky Disease Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada Aujeszky Disease Vaccines Revenue by Country (2024-2033) & (US$ Million)
Table 63. US & Canada Aujeszky Disease Vaccines Sales by Country (2018-2023) & (K Units)
Table 64. US & Canada Aujeszky Disease Vaccines Sales by Country (2024-2033) & (K Units)
Table 65. Europe Aujeszky Disease Vaccines Sales by Type (2018-2023) & (K Units)
Table 66. Europe Aujeszky Disease Vaccines Sales by Type (2024-2033) & (K Units)
Table 67. Europe Aujeszky Disease Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Aujeszky Disease Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 69. Europe Aujeszky Disease Vaccines Sales by Application (2018-2023) & (K Units)
Table 70. Europe Aujeszky Disease Vaccines Sales by Application (2024-2033) & (K Units)
Table 71. Europe Aujeszky Disease Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Aujeszky Disease Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 73. Europe Aujeszky Disease Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 74. Europe Aujeszky Disease Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Aujeszky Disease Vaccines Revenue by Country (2024-2033) & (US$ Million)
Table 76. Europe Aujeszky Disease Vaccines Sales by Country (2018-2023) & (K Units)
Table 77. Europe Aujeszky Disease Vaccines Sales by Country (2024-2033) & (K Units)
Table 78. China Aujeszky Disease Vaccines Sales by Type (2018-2023) & (K Units)
Table 79. China Aujeszky Disease Vaccines Sales by Type (2024-2033) & (K Units)
Table 80. China Aujeszky Disease Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 81. China Aujeszky Disease Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 82. China Aujeszky Disease Vaccines Sales by Application (2018-2023) & (K Units)
Table 83. China Aujeszky Disease Vaccines Sales by Application (2024-2033) & (K Units)
Table 84. China Aujeszky Disease Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 85. China Aujeszky Disease Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 86. Asia Aujeszky Disease Vaccines Sales by Type (2018-2023) & (K Units)
Table 87. Asia Aujeszky Disease Vaccines Sales by Type (2024-2033) & (K Units)
Table 88. Asia Aujeszky Disease Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia Aujeszky Disease Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 90. Asia Aujeszky Disease Vaccines Sales by Application (2018-2023) & (K Units)
Table 91. Asia Aujeszky Disease Vaccines Sales by Application (2024-2033) & (K Units)
Table 92. Asia Aujeszky Disease Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia Aujeszky Disease Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 94. Asia Aujeszky Disease Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 95. Asia Aujeszky Disease Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia Aujeszky Disease Vaccines Revenue by Region (2024-2033) & (US$ Million)
Table 97. Asia Aujeszky Disease Vaccines Sales by Region (2018-2023) & (K Units)
Table 98. Asia Aujeszky Disease Vaccines Sales by Region (2024-2033) & (K Units)
Table 99. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Type (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Type (2024-2033) & (K Units)
Table 101. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 103. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Application (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Application (2024-2033) & (K Units)
Table 105. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 107. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 108. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue by Country (2024-2033) & (US$ Million)
Table 110. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Country (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales by Country (2024-2033) & (K Units)
Table 112. IDEXX Company Information
Table 113. IDEXX Description and Major Businesses
Table 114. IDEXX Aujeszky Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. IDEXX Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. IDEXX Recent Development
Table 117. Ceva Company Information
Table 118. Ceva Description and Major Businesses
Table 119. Ceva Aujeszky Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Ceva Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Ceva Recent Development
Table 122. MSD Animal Health Company Information
Table 123. MSD Animal Health Description and Major Businesses
Table 124. MSD Animal Health Aujeszky Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. MSD Animal Health Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MSD Animal Health Recent Development
Table 127. Kyoritsuseiyaku Corporation Company Information
Table 128. Kyoritsuseiyaku Corporation Description and Major Businesses
Table 129. Kyoritsuseiyaku Corporation Aujeszky Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Kyoritsuseiyaku Corporation Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Kyoritsuseiyaku Corporation Recent Development
Table 132. CAVAC Company Information
Table 133. CAVAC Description and Major Businesses
Table 134. CAVAC Aujeszky Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. CAVAC Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. CAVAC Recent Development
Table 137. HIPRA Company Information
Table 138. HIPRA Description and Major Businesses
Table 139. HIPRA Aujeszky Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. HIPRA Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. HIPRA Recent Development
Table 142. Zendal group(CZ Vaccines) Company Information
Table 143. Zendal group(CZ Vaccines) Description and Major Businesses
Table 144. Zendal group(CZ Vaccines) Aujeszky Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Zendal group(CZ Vaccines) Aujeszky Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Zendal group(CZ Vaccines) Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Aujeszky Disease Vaccines Distributors List
Table 150. Aujeszky Disease Vaccines Customers List
Table 151. Aujeszky Disease Vaccines Market Trends
Table 152. Aujeszky Disease Vaccines Market Drivers
Table 153. Aujeszky Disease Vaccines Market Challenges
Table 154. Aujeszky Disease Vaccines Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Aujeszky Disease Vaccines Product Picture
Figure 2. Global Aujeszky Disease Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Aujeszky Disease Vaccines Market Share by Type in 2022 & 2033
Figure 4. Freeze-dried Tablet Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Aujeszky Disease Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Aujeszky Disease Vaccines Market Share by Application in 2022 & 2033
Figure 8. Sow
Figure 9. Piggy
Figure 10. Boar
Figure 11. Aujeszky Disease Vaccines Report Years Considered
Figure 12. Global Aujeszky Disease Vaccines Capacity, Production and Utilization (2018-2033) & (K Units)
Figure 13. Global Aujeszky Disease Vaccines Production Market Share by Region in Percentage: 2022 Versus 2033
Figure 14. Global Aujeszky Disease Vaccines Production Market Share by Region (2018-2033)
Figure 15. Aujeszky Disease Vaccines Production Growth Rate in North America (2018-2033) & (K Units)
Figure 16. Aujeszky Disease Vaccines Production Growth Rate in Europe (2018-2033) & (K Units)
Figure 17. Aujeszky Disease Vaccines Production Growth Rate in China (2018-2033) & (K Units)
Figure 18. Aujeszky Disease Vaccines Production Growth Rate in Japan (2018-2033) & (K Units)
Figure 19. Global Aujeszky Disease Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 20. Global Aujeszky Disease Vaccines Revenue 2018-2033 (US$ Million)
Figure 21. Global Aujeszky Disease Vaccines Revenue (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Figure 22. Global Aujeszky Disease Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 23. Global Aujeszky Disease Vaccines Revenue Market Share by Region (2018-2033)
Figure 24. Global Aujeszky Disease Vaccines Sales 2018-2033 ((K Units)
Figure 25. Global Aujeszky Disease Vaccines Sales (CAGR) by Region: 2018 VS 2022 VS 2033 (K Units)
Figure 26. Global Aujeszky Disease Vaccines Sales Market Share by Region (2018-2033)
Figure 27. US & Canada Aujeszky Disease Vaccines Sales YoY (2018-2033) & (K Units)
Figure 28. US & Canada Aujeszky Disease Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 29. Europe Aujeszky Disease Vaccines Sales YoY (2018-2033) & (K Units)
Figure 30. Europe Aujeszky Disease Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 31. China Aujeszky Disease Vaccines Sales YoY (2018-2033) & (K Units)
Figure 32. China Aujeszky Disease Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 33. Asia (excluding China) Aujeszky Disease Vaccines Sales YoY (2018-2033) & (K Units)
Figure 34. Asia (excluding China) Aujeszky Disease Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 35. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales YoY (2018-2033) & (K Units)
Figure 36. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 37. The Aujeszky Disease Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 38. The Top 5 and 10 Largest Manufacturers of Aujeszky Disease Vaccines in the World: Market Share by Aujeszky Disease Vaccines Revenue in 2022
Figure 39. Global Aujeszky Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 40. Global Aujeszky Disease Vaccines Sales Market Share by Type (2018-2033)
Figure 41. Global Aujeszky Disease Vaccines Revenue Market Share by Type (2018-2033)
Figure 42. Global Aujeszky Disease Vaccines Sales Market Share by Application (2018-2033)
Figure 43. Global Aujeszky Disease Vaccines Revenue Market Share by Application (2018-2033)
Figure 44. US & Canada Aujeszky Disease Vaccines Sales Market Share by Type (2018-2033)
Figure 45. US & Canada Aujeszky Disease Vaccines Revenue Market Share by Type (2018-2033)
Figure 46. US & Canada Aujeszky Disease Vaccines Sales Market Share by Application (2018-2033)
Figure 47. US & Canada Aujeszky Disease Vaccines Revenue Market Share by Application (2018-2033)
Figure 48. US & Canada Aujeszky Disease Vaccines Revenue Share by Country (2018-2033)
Figure 49. US & Canada Aujeszky Disease Vaccines Sales Share by Country (2018-2033)
Figure 50. U.S. Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 51. Canada Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 52. Europe Aujeszky Disease Vaccines Sales Market Share by Type (2018-2033)
Figure 53. Europe Aujeszky Disease Vaccines Revenue Market Share by Type (2018-2033)
Figure 54. Europe Aujeszky Disease Vaccines Sales Market Share by Application (2018-2033)
Figure 55. Europe Aujeszky Disease Vaccines Revenue Market Share by Application (2018-2033)
Figure 56. Europe Aujeszky Disease Vaccines Revenue Share by Country (2018-2033)
Figure 57. Europe Aujeszky Disease Vaccines Sales Share by Country (2018-2033)
Figure 58. Germany Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 59. France Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 60. U.K. Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 61. Italy Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 62. Russia Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 63. China Aujeszky Disease Vaccines Sales Market Share by Type (2018-2033)
Figure 64. China Aujeszky Disease Vaccines Revenue Market Share by Type (2018-2033)
Figure 65. China Aujeszky Disease Vaccines Sales Market Share by Application (2018-2033)
Figure 66. China Aujeszky Disease Vaccines Revenue Market Share by Application (2018-2033)
Figure 67. Asia Aujeszky Disease Vaccines Sales Market Share by Type (2018-2033)
Figure 68. Asia Aujeszky Disease Vaccines Revenue Market Share by Type (2018-2033)
Figure 69. Asia Aujeszky Disease Vaccines Sales Market Share by Application (2018-2033)
Figure 70. Asia Aujeszky Disease Vaccines Revenue Market Share by Application (2018-2033)
Figure 71. Asia Aujeszky Disease Vaccines Revenue Share by Region (2018-2033)
Figure 72. Asia Aujeszky Disease Vaccines Sales Share by Region (2018-2033)
Figure 73. Japan Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 74. South Korea Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 75. China Taiwan Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 76. Southeast Asia Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 77. India Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales Market Share by Type (2018-2033)
Figure 79. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue Market Share by Type (2018-2033)
Figure 80. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales Market Share by Application (2018-2033)
Figure 81. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue Market Share by Application (2018-2033)
Figure 82. Middle East, Africa and Latin America Aujeszky Disease Vaccines Revenue Share by Country (2018-2033)
Figure 83. Middle East, Africa and Latin America Aujeszky Disease Vaccines Sales Share by Country (2018-2033)
Figure 84. Brazil Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 85. Mexico Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 86. Turkey Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 87. Israel Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 88. GCC Countries Aujeszky Disease Vaccines Revenue (2018-2033) & (US$ Million)
Figure 89. Aujeszky Disease Vaccines Value Chain
Figure 90. Aujeszky Disease Vaccines Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed